-+ 0.00%
-+ 0.00%
-+ 0.00%

Cosmos Health's Cana Laboratories Subsidiary Signs Agreement To Produce PathMuscle For Libytec Pharmaceutical

Benzinga·01/05/2026 14:33:58
Listen to the news

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Cana Laboratories, has entered into a manufacturing and supply agreement to undertake the full end-to-end production of the pharmaceutical product PathMuscle for Libytec Pharmaceutical S.A., the product's exclusive distributor in Greece.

Under the terms of the agreement, Cosmos Health will be responsible for the complete manufacturing of the finished pharmaceutical product, including formulation, production, quality control, and product release, in accordance with applicable regulatory requirements.